Although it is known that reproducibility of ambulatory blood pressure (BP) is superior to office BP in middleaged subjects, little is known in older age groups. Hence, we compared the long-term reproducibility of ambulatory and office BP readings in subjects over the age of 75 years. A cohort of 72 subjects 75-90 years of age (mean, 82 years at baseline) had repeat office and ambulatory BPs 2 years apart under similar conditions. On the same day, patients underwent office BP measurements by a semi-automated device and then by ambulatory BP monitoring. Awake and sleep periods were divided according to a diary kept by each patient. The agreement between studies was assessed using the standard deviation of the differences (SDD) and Bland-Altman plots. There were minimal mean changes in office, 24-h, and awake and sleep mean BP values between baseline and 2 years later. The SDDs between visits were lower for 24-h BP compared with the office BP (11.7/5.9 mm Hg versus 17.8/9.0 mm Hg, Po0.01). The SDD for 24-h BP was also lower than the SDDs for the awake and sleep BP (Po0.05). Nocturnal BPs defined by absolute values were more reproducible than categories of dippers and non-dippers. These data demonstrate that long-term reproducibility of 24-h BP is superior to office measurements for very elderly subjects. In a clinical trial involving this age group, far fewer subjects would be required if 24-h BP was the primary efficacy endpoint rather than the office BP.
Introduction
Repeated ambulatory blood pressure (BP) measurements have been shown to have better reproducibility than repeated clinic (or office) BP measurements in short-and long-term studies in which there were no interventions. [1] [2] [3] This characteristic of reduced BP variability observed with ambulatory monitoring yields a reduction in sample size for clinical trials compared with the requirements when clinic BP is the endpoint. 1, [3] [4] [5] These findings have led to an increased utility of ambulatory BP as an endpoint in clinical trials as both the sample size can be reduced and an intervention can be assessed more objectively. 4, 5 Previous assessments of clinic and ambulatory BP variability have focused on middle-aged subjects who typically participate in antihypertensive trials of new therapies, 5 although one short-term study 6 evaluated the reproducibility of the morning BP surge in individuals who were over 70-years old. As the Hypertension in the Very Elderly Trial demonstrated that antihypertensive treatment in patients 480-years old is of significant benefit after a mean of only 1.8 years 7 and there is evidence that ambulatory BP has prognostic relevance in elderly patients, [8] [9] [10] [11] data on the reproducibility of BP measurements in a very elderly group would be of interest for future clinical trial development. Thus, we studied the reproducibility of clinic and ambulatory BP in a very elderly population who underwent measurements at intervals of 2 years as part of a long-term study on the relations among BP, mobility, cognitive function and the development of white matter lesions of the brain. 12 
Patients and methods

Subjects and design
The study was initiated in late 2005 with 99 subjects aged 75-89 years stratified according to age and mobility function. Of those, 95 subjects had complete testing including 24-h BP monitoring. The cohort returned for a second evaluation period in 2007-2008 coinciding with the twenty-fourth month from their initial studies. The study was approved by the Institutional Review Board at the University of Connecticut Health Center, Farmington and all subjects signed consent before any study-related procedures taking place. Subjects were excluded if they had the following: a systemic or neurological disease that limited mobility, impaired mental status, unstable cardiovascular disease (myocardial infarction in past 6 months or unstable angina, congestive heart failure or stroke), oxygen-dependence, weight 4114 kg (due to difficulty with magnetic resonance imaging (MRI) and/or successful application of the ambulatory BP recorder cuffs), metallic foreign body precluding use of MRI or a short expected lifespan (o4 years). Subjects underwent a history and physical exam to determine eligibility, and during a screening and evaluation period had determinations of duplicate clinical BP readings made on three separate office visits. The clinic BP determinations obtained on visits coinciding with the 24-h ambulatory BP monitoring were utilized in the analyses. The ambulatory BP recordings were carried out using a validated device (Oscar 2 recorder, Suntech Medical Instruments, Morrisville, NC, USA). 13 Ambulatory BP monitors were placed on weekdays and obtained automated BP values every 15 min while patients were awake and every 30 min during sleep. We strongly advocated that subjects remain physically active during the day and avoid naps. Sleep times, any symptoms and medication dosing were recorded by the subjects on patient-kept diaries.
Analytical methods
Data obtained for the ambulatory BP measurements included 24-h mean, awake and sleep systolic and diastolic BP values. Only physiologically impossible values are deleted from individual records (for example, diastolic 4systolic BP, pulse pressures o10 mm Hg). In addition, BP-surge measurements during the early morning period were calculated as the mean of first 2 h post-awakening-the mean of last 2 h pre-awakening.
Descriptive statistics were used to calculate the mean, standard deviation of the two time periods. Paired t-tests were used to test for differences between Time 2 and Time 1 (T2-T1). Standard deviation of the differences (SDD) and repeatability coefficient were calculated for all BP measurements. These values were then used to construct Bland-Altman plots 14 to determine the limits of agreement between the types of measurement differences. Pitman's test for correlated variances was used to compare the variances of the different BP measurements. 15 All analyses were carried out using SAS 9.2 (Cary, NC, USA).
The changes in the declines in BP during sleep compared with the awake period (the 'dipping' status) were calculated for each subject at study periods 1 and 2. Dipping and non-dipping status were defined as X10% reduction in nocturnal systolic BP relative to awake systolic and 0 to o10% reduction in nocturnal systolic BP, respectively. Change in dipping status was calculated as one of the following potential scenarios: (a) dipper remaining a dipper; (b) dipper changing to a nondipper; (c) non-dipper remaining a non-dipper; and (d) non-dipper changing to a dipper. Changes in absolute values of nocturnal hypertension using values of nocturnal systolic BPX120 and 125 mm Hg to define hypertension and a nocturnal systolic BPo120 and 125 mm Hg to define normotension as previously described. 16 Evaluation of the effect of BP variability on sample size requirements for a clinical trial in the very elderly using power of 80% and P ¼ 0.05 in a two-tailed test was calculated, varying the effect size of systolic BP between 3 and 9 mm Hg.
Results
Subjects
There were initially 99 subjects enrolled in the study with a mean age of 82±3.8 years. Of this group, 95 completed an ambulatory BP recording (Table 1) . Two years later, a total of 23 subjects had died, moved into a convalescent home, had a pacemaker implant or declined participation in the 24-h BP monitoring portion of the study leaving 72 subjects in the final analysis. Of the subjects who enrolled into the study, 70% had hypertension, 13% had coronary artery disease, 6% had diabetes and 48% had dyslipidemia (low-density lipoprotein cholesterol 4130 mg 100 ml À1 ). Of the 72 subjects who had BP monitors at baseline and following 2 years, there were no major changes in body weight (mean BMI: 26.8 versus 26.3 kg/m 2 ) and only 3 patients had major interval medical problems: development of stroke, heart failure or valvular disease. There were 3 patients who stopped antihypertensive therapy and 4 patients who were initiated on antihypertensive therapy. Clinical decisions related to drug therapies were made by the patient's primary care physician without input from the study staff.
Mean clinic and ambulatory BP measurements
There were no differences between repeated measurements for the majority of the clinic, 24-h, and awake and sleep BPs over the 2 year period; exceptions were the clinic diastolic BP, pre-awakening systolic BP, sleep pulse pressure and post-awakening pulse pressure (Table 1) . For both baseline and repeat measurements the ambulatory BP readings were slightly lower than the clinic measurements reflecting the usual effect of sleep on the 24-h BP values (Table 1) .
Repeated 24-h systolic and diastolic BP had significantly less variability and hence, greater reproducibility compared with clinic BP (systolic SDD: 11.6 versus 17.8 mm Hg and diastolic SDD, 9.0 versus 6.0 mm Hg, for 24-h versus clinic, respectively, Po0.01 for both, Table 1 ). The SDD of the 24-h mean BP was also lower than awake and sleep BPs ( Table 1) . In contrast, early morning BPs (both pre-and postawake systolic BP) had SDDs similar to that of the clinic BPs. As expected, the reproducibility for the pulse pressure (systolic and diastolic BP) was between the reproducibility of systolic and diastolic pressure ( Table 1) . Results of the 65 subjects who had no changes in antihypertensive medications over the same 2-year period were unchanged from the data shown in Table 1 (data not shown).
Analyses of the Bland-Altman plot for clinic and 24-h ambulatory systolic pressures are shown in Figure 1 . The limits of agreement for the clinic systolic BP are substantially larger than for the 24-h ambulatory systolic BP. The upper and lower limits of agreement across a wide range in systolic BPs were 35.5 and À35.5 mm Hg for the clinic pressure and 24.5 mm Hg and À22.3 mm Hg for the 24-h BPs, respectively.
Analysis of nocturnal BP classifications
The changes in categories of circadian BP profiles according to nocturnal declines in BP during sleep over 2 years are shown in Table 2 . Of the subjects who were initially classified as dippers (410% reduction in nocturnal systolic BP relative to awake systolic BP), 30% remained dippers at the second evaluation and 70% converted to another category. Similarly, of the 24 patients who were initially classified as non-dippers (0 to o10% reduction in nocturnal systolic BP), 42% remained non-dippers at the second evaluation and 58% converted to another category. In total 60% patients changed their dipping status over the 2-year period of assessment. Changes in hypertensive status based on absolute nocturnal systolic BP demonstrated improved reproducibility compared with categorical changes ( Table 2) . For those patients originally classified as having nocturnal hypertension (based on a systolic BPX 120 or X125 mm Hg), 83% and 70%, respectively remained in the hypertensive category 2 years later; for those originally classified as normotensive (based on systolic BPo120 and o125 mm Hg), 66 and 75%, respectively remained normotensive 2 years later.
Effect of reproducibility on sample size requirements for a clinical trial
Sample size calculations for a very elderly population being evaluated in a clinical interventional trial is shown in Table 3 across a variety of estimated mean effects. As shown in the table, a much smaller study population could be used to detect an effect of an intervention on systolic BP or pulse pressure using 24-h BP versus clinic BP (for example, for mean changes in systolic BP of 5 mm Hg, 85 versus 198 subjects per treatment arm). The required sample size would also be less if awake or sleep BP was the endpoint of interest; in contrast, assessment of changes in the early morning BP would require a large sample, similar to that of the clinic BP (Table 3 ).
Discussion
Principal findings
Our study demonstrated that in a very elderly patient group, unselected with regard to hypertensive status, 24-h ambulatory BP measurements were substantially more reproducible than standardized measurements carried out in the clinic (or office) environment. Both the systolic and diastolic BP, as well as the pulse pressure, showed this pattern. As the ambulatory BP components were broken into smaller segments of time (for example, the awake, sleep or early morning period), the reproducibility lessened but the awake and sleep BP variability was still less than that observed in the clinic. These findings show that in this older population, interventional studies with non-drug or drug therapies could use much smaller sample sizes if the ambulatory BP was used as the primary efficacy endpoint relative to the sample size required than if the clinic BP was used as the primary endpoint.
Comparisons with previous studies on clinic and ambulatory BP reproducibility
Our data show relatively similar results to the findings in younger subjects that demonstrate that the reproducibility of the 24-h BP is superior to that of the clinic BP in both short-term 17, 18 and longerterm assessments. 5, 6 However, as our patient group belongs to a much older population, we focused on systolic and pulse pressure, which are of greater prognostic importance than diastolic BP and would be a more likely target for intervention. 7, 10, 11 As in other studies, the systolic BP variability for clinic BP is nearly twice that of the 24-h systolic BP ( Table 1 ). The findings of Mansoor et al. 5 are similar to the present results-in that study, long-term evaluation of 24-h ambulatory BP revealed superior reproducibility over office BP with a SDD for 24-h BP of 9.8 mm Hg versus 17 mm Hg for the office pressure.
Classification of nocturnal BP decline
The classification of patients according to the decline in nocturnal BP has been highly controversial. Indeed, in our study of a very elderly cohort, approximately 60-70% of patients changed their dipping versus nondipping status over the 2 years based on repeat 24-h BP measurements. Our data confirm results of other studies that have reported a poor reproducibility of dipping status. [17] [18] [19] [20] [21] We advocated in the past that the absolute nocturnal BP values were a more sensible means to assess the effects of antihypertensive therapy 16 because it is more reproducible than dipping status. The finding that 34% fewer patients had a change in their nocturnal BP classification when using absolute nocturnal BP values confirms the improved reproducibility ( Table 2 ). Our findings have been corroborated by Burr and colleagues 6 who demonstrated that night-time BP is the strongest predictor of cardiovascular outcome in an older population in Ireland. Although the PAMELA study 22 reported high cardiovascular mortality associated with a blunted nocturnal dipping pattern, it is unclear how one can practically use that information in individual patients when the reproducibility of an individual patients' dipping status is so poor ( Table 2) .
Impact of our findings on clinical trials in very old hypertensive subjects
Previous studies, which were carried out two decades ago, showed that a significant reduction in study size could be attained if ambulatory BP was used rather than clinic BP in a short-term trial. 4 In fact, it was determined that a 50% reduction in the SDD as an indicator of BP variability would translate to a 75% reduction in sample size needed in a clinical trial. 1, 4 We have determined fairly similar results in a much older population and one in which the follow-up period is much longer and similar to that of Hypertension in the Very Elderly Trial. 7 In fact, if one was trying to plan a study to determine if an active agent could lower systolic BP by at least 4 mm Hg better than a placebo in a patient population 480 years of age, using 24-h BP as the primary endpoint would lower the sample size by 67% (Table 4 ). Until Hypertension in the Very Elderly Trial, lack of experience in the very elderly population with regards to outcomes, kept this important patient group out of clinical trials; that should no longer be the case and our data support using 24-h systolic BP as the primary endpoint in clinical trials of antihypertensive therapies.
Study limitations
The proportion of subjects from the cohort available for assessment at year 2 declined substantially because of death and disability. Of the 23 subjects unavailable, only 5 subjects were unavailable because of unwillingness to wear the ABP recorder. Of the 72 patients who wore the monitor twice, 71 of these patients had complete data (nocturnal BP was missing in 1 subject (Table 3) ). The results of our study suggest that in carrying out a clinical trial of the very elderly using ambulatory BP recordings, expectations for a 20-25% loss of data in a long-term study would be appropriate and the sample size calculations should take this into consideration.
Conclusions
The results of this study demonstrate that the reproducibility of 24-h systolic and pulse pressure are superior to the office BP in very elderly subjects. This translates into major impact on the sample size of a clinical trial if 24-h ambulatory BP was used as an endpoint rather than office BP; in fact, a reduction in the required sample by 67%. Similar to findings in a middle-aged population, we also found that defining nocturnal hypertension using absolute values is more reproducible than using categories of nocturnal hypertension related to changes from day to night.
